0001493152-24-004815.txt : 20240202
0001493152-24-004815.hdr.sgml : 20240202
20240202200015
ACCESSION NUMBER: 0001493152-24-004815
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240202
FILED AS OF DATE: 20240202
DATE AS OF CHANGE: 20240202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SNYDER DAVID S
CENTRAL INDEX KEY: 0001398625
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41583
FILM NUMBER: 24593563
MAIL ADDRESS:
STREET 1: ONE SCIENCE COURT
CITY: MADISON
STATE: WI
ZIP: 53711
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Coya Therapeutics, Inc.
CENTRAL INDEX KEY: 0001835022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12645 MEMORIAL DR., SUITE F1 #305
CITY: HOUSTON
STATE: TX
ZIP: 77024
BUSINESS PHONE: 650.739.3939
MAIL ADDRESS:
STREET 1: 12645 MEMORIAL DR., SUITE F1 #305
CITY: HOUSTON
STATE: TX
ZIP: 77024
4
1
ownership.xml
X0508
4
2024-02-02
0
0001835022
Coya Therapeutics, Inc.
COYA
0001398625
SNYDER DAVID S
5850 SAN FELIPE ST., SUITE 500
HOUSTON,
TX
77057
0
1
0
0
Chief Financial Officer
0
Stock Option (right to buy)
5.90
2024-01-31
4
A
0
81819
0
A
2034-01-31
Common Stock
81819
81819
D
The option will vest in 36 equal monthly installments commencing February 29, 2024, subject to continuous service on each vesting date.
/s/ David Snyder
2024-02-02